T. Rowe Price
Signal active
Investment Firm
Overview
T. Rowe Price is an investment management firm dedicated to funding technology startups. The firm serves individuals, financial intermediaries, and institutions and offers a full range of investment strategies across a broad spectrum: debt, equities, and private equities.
Highlights
Founded
1937
Industry
Financial Services
Employees
5001-10000
Investment
353
Lead Investment
102
Exits
138
Stages
Early Stage Venture, Late Stage Venture, Private Equity
Investor Type
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
T. Rowe Price, established in 1937 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity investments across Financial Services, Finance, News, Foreign Exchange Trading, Consulting, Advice, Venture Capital, Consumer, Health Care, Angel Investment. The organization boasts a portfolio of 348 investments, with an average round size of $321.2M and 138 successful exits. Their recent investments include OANDA Corporation, Cascade Investment, New Enterprise Associates, Index Ventures, Legg Mason. The highest investment round they participated in was $13482.4B. Among their most notable exits are OANDA Corporation and Cascade Investment. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
T. Rowe Price has made 353 investments. Their most recent investment was on Aug 05, 2024, when MBX Biosciences raised $63.5M.
T. Rowe Price has made 61 diversity investments. Their most recent diversity investment was on Jul 11, 2024, when Element Biosciences raised $277.0M.
investments
353
Diversity investments
61
Lead investments
102
Number of exits
138
Investments
353
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 23, 2024 | Clio | Software | 900.0M |
| Jul 23, 2024 | - | - | 165.0M |
| Jul 24, 2024 | Kestra Medical Technologies, Inc. | Health Care | 196.0M |
| Aug 05, 2024 | MBX Biosciences | Biotechnology | 63.5M |
Exits
138
Funding Timeline
Funding rounds
353
Investors
0
Funds
0
Funding Rounds
353
T. Rowe Price has raised 353 rounds. Their latest funding was raised on Aug 05, 2024 from a Series C - MBX Biosciences round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 23, 2024 | Series F - Clio | - | 900.0M | - |
| Jul 23, 2024 | Series A - Third Arc Bio | - | 165.0M | - |
| Jul 24, 2024 | Private Equity Round - Kestra Medical Technologies, Inc. | - | 196.0M | - |
| Aug 05, 2024 | Series C - MBX Biosciences | - | 63.5M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.